Health technology firm started by Dallas native lands $175 million investment to expand

Austin-based health technology company Everlywell has raised $175 million to expand its digital health offerings and its workforce.

Everlywell was founded by Dallas native Julia Cheek in 2015, and the company moved to Austin in 2016.

Everlywell focuses on home health care diagnostics, including at-home tests for food sensitivity, allergies, thyroid issues, hormones and vitamins. The company also has received authorization for an at-home test kit for COVID-19.

New investors in the financing round include funds and accounts managed by BlackRock, the Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures and Portfolia, as well as existing investors Goodwater Capital, Highland Capital Partners and Next Coast Ventures.

This investment brings the total capital raised by the company to more than $250 million.

“The pandemic has shed light on the challenges of lab testing for Americans, from unknown costs to confusion and inconvenience,” Cheek said. “We’ve been empowering people with

Read More

Health tech venture firm OTV closes new $170 million fund and expands into Asia

OTV (formerly known as Olive Tree Ventures), an Israeli venture capital firm that focuses on digital health tech, announced it has closed a new fund totaling $170 million. The firm also launched a new office in Shanghai, China to spearhead its growth in the Asia Pacific region.

Loading...

Load Error

OTV currently has a total of 11 companies in its portfolio. This year, it led rounds in telehealth platforms TytoCare and Lemonaid Health, and its other investments include genomic machine learning platform Emedgene; microscopy imaging startup Scopio; and at-home cardiac and pulmonary monitor Donisi Health. OTV has begun investing in more B and C rounds, with the goal of helping companies that already have validated products deal with regulations and other issues as they grow.

OTV focuses on digital health products that have the potential to work in different countries, make healthcare more affordable, and fill gaps in overwhelmed healthcare systems.

Read More

Leak left 243 million Brazilians’ medical records and personal info ripe for the picking

The personal information of more than 243 million Brazilians was potentially accessible for at least six months thanks to weakly encoded credentials kept in the source code of the Brazilian Ministry of Health’s website (via ZDNet). The security issue was first reported by Brazilian publication Estadão.

The personal data of anyone who had registered with Sistema Único de Saúde (SUS), Brazil’s national health system, could be viewed. That data included people’s full names, addresses, and telephone numbers, reported Estadão. The database also includes records of living and dead people as the population of Brazil was more than 211 million in 2019, according to The World Bank, which is about 32 million fewer people than the reported number of records that were potentially accessible.

The Ministry of Health’s website stored the encoded access credentials to the database of personal information in its source code, reports Estadão. However, the

Read More

Certara Seeks $500 Million U.S. IPO

Certara (CERT) and selling shareholders intend to raise an estimated $500 million in an IPO of its common stock, according to an S-1 registration statement.

Princeton, New Jersey-based Certara was founded to develop biosimulation software to assist biopharmaceutical companies in conducting virtual trials to predict how drugs might behave in patients.

Management is headed by William Feehery, Ph.D, who has been with the firm since June 2019 and was previously president of DuPont Industrial Biosciences

Below is a brief overview video of Certara:

Source: Certara

The firm’s primary markets include:

  • Biosimulation
  • Regulatory Science
  • Market Access

Certara has received at least $510 million from investors including EQT AB and Arsenal Investors.

The company pursues biopharmaceutical firms via a direct sales and marketing approach and had more 1,600 biopharma companies and academic institutions in 60 countries as customers as of the end of 2019.

Additionally, numerous regulatory authorities are customers, including the

Read More

Rider University receives $4 million gift to fund expansion of Science and Technology Center

The one-story addition will expand the size of the building to more than 79,000 sq. ft. and provide modern labs and classroom space for cybersecurity, anatomy and physiology, as well as an evolving program in software engineering. The $7.5 to $8 million project will support a new greenhouse, along with distinct areas meant to encourage collaboration and study.

“We’re particularly excited about this leadership gift for our Science and Technology Center expansion project,” says Rider President Gregory G. Dell‘Omo, Ph.D. “We’ve seen tremendous growth in our science majors and this construction project will provide us with an opportunity to introduce new, high demand majors.”

Hennessy met his wife, Patrice “Patti” Shelmet Hennessy ’82, at Rider when they were both students. Patti, who passed away in January after a long illness, graduated with a bachelor’s in office administration. Hennessy, who earned a bachelor’s in political science, is the founder and

Read More

Ortho Regenerative Technologies Completes Non-Brokered $3.0 Million Private Placement

MONTREAL, Dec. 3, 2020 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTCQB: ORTIF) (“Ortho RTI” or the “Company“), an emerging orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, announced today that it has completed a non-brokered private placement of secured non-convertible debenture units for gross proceeds of $3.0 million (the “Offering“).

“We would like to thank all contributors to this private placement, including $350,000 from insiders and employees, and with a special thanks to a long-time shareholder from Leede Jones Gables, whose bold contribution to this non-dilutive financing helps to solidly position the Company with the resources to continue executing and delivering multiple important milestones over the coming months”, said Claude LeDuc, CEO of Ortho RTI. “Our IND filing will be ready in the coming weeks and we are confident to submit to the FDA

Read More

Pigment raises $25.9 million to ‘reboot the spreadsheet’ with next-gen business forecasting

Pigment, which is setting out to “reboot the spreadsheet” and give businesses a “multidimensional view” of their data with its platform, has raised $25.9 million in a series A round of funding led by Blossom Capital.

Founded out of Paris in 2019, Pigment touts itself as a business forecasting platform that circumvents the limitations of “error-prone” spreadsheets and inflexible software to bring a “new standard” to planning and modeling. The platform is still in closed beta, though the company claims to have secured some undisclosed high-profile clients, including a major European bank and pre-IPO startups.

Pigment’s founding team includes co-CEOs Eléonore Crespo, a former financial analyst at Google who later joined Index Ventures as an investor, and Romain Niccoli, cofounder and former CTO of advertising tech giant Criteo.

Incumbents

Pigment is entering a space occupied by some long-standing incumbents, including Anaplan, Workday (which acquired Adaptive Insights in 2018), and trusty

Read More

Flipkart’s digital payments firm PhonePe to raise $700 million from existing investors

NEW DELHI (Reuters) – PhonePe, the digital payments unit of Walmart’s Indian e-commerce arm Flipkart, said on Thursday it would sell a stake to existing investors for $700 million, helping it fuel growth in a crowded market that includes Google and Amazon .

FILE PHOTO: The logo of India’s e-commerce firm Flipkart is seen in this illustration picture taken January 29, 2019. REUTERS/Danish Siddiqui/Illustration

PhonePe’s fundraising, from Flipkart investors led by Walmart, will give it a valuation of $5.5 billion, the company said in a statement.

PhonePe is also using the opportunity to assert its independence from the Flipkart Group which runs a successful e-commerce business in India rivalling Amazon’s local unit.

It will have its own board of directors, which will include founder and CEO Sameer Nigam and former Flipkart boss Binny Bansal, who is no longer at the company he co-founded.

PhonePe will also have employee stock ownership

Read More

Ondas Readies $30 Million Nasdaq Uplisting

Ondas (ONDS) intends to raise $30 million from the sale of its common stock in an uplisting/Nasdaq public offering, according to an amended registration statement.

Sunnyvale, California-based Ondas Networks was founded in 2006 to provide wireless data radio technologies for IoT applications in the electric utilities, oil & gas, water, rail, transportation as well as government industries.

Management is headed by Chairman and CEO Eric A. Brock, who has been with the firm since 2017 and was previously Portfolio Manager at Clough Capital Partners.

Ondas’ lead product is FullMAX, a software defined radio [SDR] system consisting of a wireless base station, fixed and mobile remote radios as well as supporting technology for wide-area broadband networks that enable secure industrial-grade connectivity.

The company’s SDR equipment is fully IEEE 802.16s compliant, has the ability to use frequencies between 30 MHz and 6 GHz, and has a wide coverage of up to 30

Read More

CZI Awards Nearly $32 Million and Announces New Funding Opportunity to Advance Biomedical Imaging

REDWOOD CITY, Calif., Dec. 2, 2020 /PRNewswire/ — Imaging of proteins, cells, and tissues is critical to understanding health and disease. Today, the Chan Zuckerberg Initiative (CZI) announced nearly $32 million in funding to support biomedical imaging researchers, technology development, and the BioImaging North America international network of bioimaging facilities and communities. CZI also opened a new Request for Applications (RFA) aimed at supporting technology development that will allow researchers to see the inner workings of cells, including proteins, at near-atomic resolution to better understand what causes disease and how to develop treatments.

“We want to enable researchers everywhere to visualize, measure, and analyze the biological processes underlying health and disease,” said CZI Head of Science, Cori Bargmann. “That means taking multiple approaches. We’re pushing the frontiers with our Deep Tissue Imaging grants, we’re supporting Imaging Scientists—the key technology experts who disseminate new advances—and we’re building community with BioImaging North

Read More